These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20130980)

  • 1. Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".
    Fehm T; Sauerbrei W
    Breast Cancer Res Treat; 2010 Jul; 122(1):219-20. PubMed ID: 20130980
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
    Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
    Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
    Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K
    Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
    Danila DC; Heller G; Gignac GA; Gonzalez-Espinoza R; Anand A; Tanaka E; Lilja H; Schwartz L; Larson S; Fleisher M; Scher HI
    Clin Cancer Res; 2007 Dec; 13(23):7053-8. PubMed ID: 18056182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.
    Abu-Khalaf MM; Harris L
    Breast Cancer Res Treat; 2009 Apr; 114(3):513-5. PubMed ID: 18677560
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
    Cristofanilli M; Budd GT; Ellis MJ; Stopeck A; Matera J; Miller MC; Reuben JM; Doyle GV; Allard WJ; Terstappen LW; Hayes DF
    N Engl J Med; 2004 Aug; 351(8):781-91. PubMed ID: 15317891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells as prognostic marker in metastatic breast cancer.
    Andreopoulou E; Cristofanilli M
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):171-7. PubMed ID: 20131993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor markers in breast cancer management.
    Lenahan C; Garibyan L; Pories S
    Curr Surg; 2004; 61(6):532-7. PubMed ID: 15590016
    [No Abstract]   [Full Text] [Related]  

  • 12. Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage.
    Kahn HJ; Presta A; Yang LY; Blondal J; Trudeau M; Lickley L; Holloway C; McCready DR; Maclean D; Marks A
    Breast Cancer Res Treat; 2004 Aug; 86(3):237-47. PubMed ID: 15567940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells in breast cancer: blood will tell.
    Sledge GW
    Clin Cancer Res; 2006 Nov; 12(21):6321-2. PubMed ID: 17085639
    [No Abstract]   [Full Text] [Related]  

  • 14. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
    Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
    Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.
    Hayes DF; Cristofanilli M; Budd GT; Ellis MJ; Stopeck A; Miller MC; Matera J; Allard WJ; Doyle GV; Terstappen LW
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4218-24. PubMed ID: 16857794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells and emerging blood biomarkers in breast cancer.
    Criscitiello C; Sotiriou C; Ignatiadis M
    Curr Opin Oncol; 2010 Nov; 22(6):552-8. PubMed ID: 20706122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.